FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32687111000001108: Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99835001000001115 Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100801401000001119 Bendamustine 100mg powder for concentrate for solution for infusion vials (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Is a Bendamustine 100mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has active ingredient Bendamustine true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Bendamustine hydrochloride true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has AMP True Bendamustine 100mg powder for concentrate for solution for infusion vials (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start